Abstract: A system and a method for managing presence information on a person's presence in a free address office, which can be updated and adjusted with less time and effort for adaptation to a change in the office layout, and can efficiently collect information about the person's health. The system includes an in-room camera and an information collection robot. Upon detection of a seated person, the robot moves toward an area where the seated person is detected and captures a face image of the seated person with a face camera therein. Then, the system performs a face verification operation based on the face image to identify the seated person and generates the person's presence information. The system may also generate information on whether a person is wearing a mask or not, and/or acquire a person's vital information from a vital sensor in the robot.

Abstract: Disclosed is a sustained release preparation which releases a poorly soluble medicinal agent in a pH-independent manner. Also disclosed is a sustained release preparation which is capable of controlling the Cmax of a medicinal agent to an adequate amount and is thus capable of maintaining the level of the medicinal agent in the blood to a level at which medicinal effects can be expected for a long period of time. Specifically disclosed is a sustained release preparation which is characterized by containing a pharmaceutically acceptable salt of 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(3-pyridylmethylamino)-3(2H)-pyridazinone, and hypromellose. An organic acid is blended in the sustained release preparation in an amount of less than 1% by mass.

Abstract: Disclosed is a sustained release preparation which releases a poorly soluble medicinal agent in a pH-independent manner. Also disclosed is a sustained release preparation which is capable of controlling the Cmax of a medicinal agent to an adequate amount and is thus capable of maintaining the level of the medicinal agent in the blood to a level at which medicinal effects can be expected for a long period of time. Specifically disclosed is a sustained release preparation which is characterized by containing a pharmaceutically acceptable salt of 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(3-pyridylmethylamino)-3(2H)-pyridazinone, and hypromellose. An organic acid is blended in the sustained release preparation in an amount of less than 1% by mass.

Abstract: A control characteristics changing unit reads, from an EEPROM, various control parameters in an ANC electronic controller, which correspond to specification information acquired from ECUs. The control characteristics changing unit then outputs control parameters, depending on changed specification information among the read control parameters, as change signals Sm1 through Sm6 to a basic signal generating unit, reference signal generating units, filter coefficient updating units, corrective signal generating units, switches, and variable-gain amplifiers, respectively.